Le Quotidien du Médecin La Food and Drug Administration vient de donner son agrément à Trulicity (dulaglutide, laboratoires Eli Lilly), un analogue du glucagon like peptide -1 (GLP-1), qui s'administre en injection sous-cutanée une fois par semaine. Trulicity a été étudié au ...
Diabetes News Journal “Type 2 diabetes is a serious chronic condition that causes blood glucose levels to rise higher than normal,” said Mary Parks, M.D., deputy director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research. “Trulicity is ... and more »
SYS-CON Media (press release) Actos, a widely prescribed diabetes medication since 1999, is a type of thiazolidinedione (TZD) that has been connected to a slew of serious side effects such as bladder cancer, cardiovascular problems, liver issues and bone fractures. It was reported ... and more »
A Sweet Life The treatment was tested as a stand-alone drug , as well as being used alongside existing treatments, including metformin, sulfonylurea, thiazolidinedione...
Marketwired (press release) It will be evaluated in conjunction with current treatments such as metformin, thiazolidinedione and/or long-acting insulin analog on glycemic control in patients with Type 2 diabetes. ... and commercializing therapeutic molecules that address diabetes ... and more »
ModernMedicine The GLP-1 receptor agonist was used alone or in combination with other commonly prescribed diabetes medications , including metformin, sulfonylurea, thi...
